Introduction Lurie Children's Hospital is a pediatric healthcare facility that employs state-of-the-art medical technology, research, and family-centric design to provide exceptional care. The hospital offers a wide range of services including allergy and immunology, brain tumors, oncology, neurosurgery, palliative care, emergency medicine, and fetal conditions. With a strong commitment to research and education, Lurie Children's Hospital is dedicated to advancing the understanding, prevention, and treatment of pediatric illnesses and injuries. |
Disease Domain | Count |
---|---|
Endocrinology and Metabolic Disease | 1 |
Immune System Diseases | 1 |
Nervous System Diseases | 1 |
Neoplasms | 1 |
Top 5 Drug Type | Count |
---|---|
Therapeutic vaccine | 1 |
Synthetic peptide | 1 |
Top 5 Target | Count |
---|---|
HSP(Heat-shock protein) | 1 |
Target |
Mechanism HSP stimulants |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
Start Date01 May 2025 |
Sponsor / Collaborator |
Start Date01 Mar 2025 |
Sponsor / Collaborator |
Start Date01 Mar 2025 |
Sponsor / Collaborator |
Drug(Targets) | Indications | Global Highest Phase |
---|---|---|
rHSC-DIPGVax(Dana-Farber Cancer Institute) ( HSP ) | Dimethylglycine Dehydrogenase Deficiency More | Phase 1 |
AIF-PAs | Crohn Disease More | Preclinical |